Mottagare av CIMED projektbidrag 2026-2028

Vi gratulerar de forskare vid MedH som har tilldelats CIMED-projektbidrag för perioden 2026-2028.
Följande forskare vid Institutionen för medicin, Huddinge har tilldelats projektbidrag från CIMED:
Annika Bergquist - Primary sclerosing cholangitis (PSC) - Improvement of the prognosis by statin treatment and increased knowledge of the pathogenesis.
Andreas Björklund - FasI/IIprövningmedadaptivaNK-celler mot behandlings refraktärt myelodysplastiskt syndrom och akut myeloisk leukemi.
Niklas Björkström - Personalizing immunosuppression in organ transplantation via integration of spatial immunology.
Yenan Bryceson - Improving molecular diagnostics for children with severe inborn errors of immunity.
Rafael Ceña Diez - Approaching a clinical evaluation of a novel natural vaginal microbicide against HIV and sexually transmitted infections.
Emmanouil Charitakis - Assessment of the effect of catheter ablation on elderly population with atrial fibrillation; a randomized controlled study; The ACE-AF study.
Martin Cornillet - Deep proteomic trajectories in Primary Sclerosing Cholangitis for the discovery of new mechanisms driving autoimmunity, liver fibrosis and bowel inflammation.
Hannes Hagström - Clinical and epidemiological projects to improve management of liver disease.
Eva Hellström-Lindberg - From identified molecular targets to improved outcome for patients with myelodysplastic syndromes.
Juha Kere - Prediktion och tidig diagnos av pre-eklampsi.
Andreas Lennartsson - Targeting resistance to Menin inhibitors in acute myeloid leukemia.
Agneta Månsson-Broberg - Genetic predisposition, new biomarkers and senescence footprint and their impact on cancer therapy-related cardiovascular dysfunction.
Anna Norrby-Teglund - Precision medicine in sepsis: mapping gene signatures to immune responses to enable tailored immunomodulatory therapy in sepsis.
Ghada Nouairia - Developing clinical tools for early detection and risk stratification of biliary tract cancers (BTC).
Thomas Poiret - Enhancing chimeric antigen receptor (CAR) outcome by refining cell content and starting material quality.
Mikael Rydén - Clinical studies of insulin resistance in white adipose tissue-from adipose heterogeneity to precision medicine.
Peter Saliba Gustafsson - Dissecting the genomics and single-cell transcriptome of Metabolic Dysfunction-Associated Fatty Liver Disease: From molecular signatures to therapeutic targets.
Benedikt Strunz - A functional atlas of immunosuppression in blood and tissue.
Peter Svensson - Deciphering HIV-1 Reservoir Dynamics to Achieve ART-Free Long-Term Remission.
Anders Sönnerborg - HIV-1 latency and its reactivation in search for functional HIV-1 cure.